Zobrazeno 1 - 10
of 1 498
pro vyhledávání: '"S. Finn"'
Autor:
G. G. Alvarez, D. Van Dyk, R. Mallick, S. Lesperance, P. Demaio, S. Finn, S. Edmunds Potvin, M. Patterson, C. Pease, K. Amaratunga, C. Hui, D.W. Cameron, S. Mulpuru, S.D. Aaron, F. Momoli, A. Zwerling
Publikováno v:
International Journal of Circumpolar Health, Vol 79, Iss 1 (2020)
Background: The incidence of TB among Inuit is the highest in Canada. A significantly shorter latent TB infection (LTBI) treatment with rifapentine and isoniazid once weekly for 12 weeks (3HP) is now available in limited settings in Canada. Methods:
Externí odkaz:
https://doaj.org/article/16425fe448d14bd6920642445f46808f
Publikováno v:
EuPA Open Proteomics, Vol 10, Iss C, Pp 19-23 (2016)
Laser capture microdissection (LCM) allows microscopic procurement of specific cell types from tissue sections. Here, we present an optimized workflow for coupling LCM to LC–MS/MS including: sectioning of tissue, a standard LCM workflow, protein di
Externí odkaz:
https://doaj.org/article/bf7aa297eabe4956b77a518f6631f6b5
Autor:
Hyung-Don Kim, Seyoung Jung, Ho Yeong Lim, Baek-Yeol Ryoo, Min-Hee Ryu, Hong Jae Chon, Beodeul Kang, Jung Yong Hong, Han Chu Lee, Deok-Bog Moon, Ki-Hoon Kim, Tae Won Kim, Jeong Seok Lee, Richard S. Finn, June-Young Koh, Changhoon Yoo
Regorafenib plus nivolumab (RegoNivo) combination has shown promising anti-cancer activity in multiple cancer types. REBNOBATE trial is a single-arm multicenter phase 2 trial of first-line RegoNivo in patients (pts) with uHCC (NCT04310709). Here we r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e24ad3eff16aefcb685092da825f8c7
Publikováno v:
The Journal of Neuroscience. 43:3849-3859
A defining feature of children's cognition is the especially slow development of their attention. Despite a rich behavioral literature characterizing the development of attention, little is known about how developing attentional abilities modulate ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::989f50d966942de683aaa308a266b79c
https://doi.org/10.1523/jneurosci.0159-23.2023
https://doi.org/10.1523/jneurosci.0159-23.2023
Publikováno v:
Nature Reviews Psychology. 2:205-219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ae25c4eb5863edd8278986e4ee4792c
https://doi.org/10.1038/s44159-023-00157-0
https://doi.org/10.1038/s44159-023-00157-0
Autor:
Lucia Sanchez, Fernando A. Escobar, Laura S. Finn, Kristin D. Gerson, Matthew Janssen, Michael R. Acord
Publikováno v:
Pediatric Radiology. 53:1211-1215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cae693737326b19a6155d864ca5b26cb
https://doi.org/10.1007/s00247-023-05625-6
https://doi.org/10.1007/s00247-023-05625-6
Autor:
Hope S Rugo, Adam Brufsky, Xianchen Liu, Benjamin Li, Lynn McRoy, Connie Chen, Rachel M Layman, Massimo Cristofanilli, Mylin A Torres, Giuseppe Curigliano, Richard S Finn, Angela DeMichele
Publikováno v:
Future Oncology. 19:489-498
What is this summary about? This is a summary of an article about a study called “P-REALITY X” that was published in the medical journal npj Breast Cancer in October 2022. “P-REALITY X” stands for Palbociclib REAl-world first-LIne comparaTive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::467363b9001c3bb605d5d07e09811739
https://doi.org/10.2217/fon-2022-1192
https://doi.org/10.2217/fon-2022-1192
Autor:
Amy S. Clark, Fangxin Hong, Richard S. Finn, Angela M. DeMichele, Edith P. Mitchell, James Zwiebel, Fernanda I. Arnaldez, Robert J. Gray, Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Stanley R. Hamilton, Mehmet S. Copur, Samer S. Kasbari, Ravneet Thind, Barbara A. Conley, Carlos L. Arteaga, Peter J. O'Dwyer, Lyndsay N. Harris, Alice P. Chen, Keith T. Flaherty
Publikováno v:
Clinical Cancer Research. 29:1477-1483
Purpose: Cyclin D/CDK4/6 is critical in controlling the G1 to S checkpoint. CCND, the gene encoding cyclin D, is known to be amplified in a variety of solid tumors. Palbociclib is an oral CDK4/6 inhibitor, approved in advanced breast cancer in combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0deaba3a14fb4dcac6730d29e90dbb46
https://doi.org/10.1158/1078-0432.ccr-22-2150
https://doi.org/10.1158/1078-0432.ccr-22-2150
Autor:
Na Sun, Ceng Zhang, Yi‐Te Lee, Benjamin V. Tran, Jing Wang, Hyoyong Kim, Junseok Lee, Ryan Y. Zhang, Jasmine J. Wang, Junhui Hu, Zhicheng Zhang, Manaf S. Alsudaney, Kuan‐Chu Hou, Hubert Tang, Tiffany X. Zhang, Icy Y. Liang, Ziang Zhou, Mengxiang Chen, Angela Hsiao‐Jiun Yeh, Wenyuan Li, Xianghong Jasmine Zhou, Helena R. Chang, Steven‐Huy B. Han, Saeed Sadeghi, Richard S. Finn, Sammy Saab, Ronald W. Busuttil, Mazen Noureddin, Walid S. Ayoub, Alexander Kuo, Vinay Sundaram, Buraq Al‐Ghaieb, Juvelyn Palomique, Kambiz Kosari, Irene K. Kim, Tsuyoshi Todo, Nicholas N. Nissen, Maria Lauda Tomasi, Sungyong You, Edwin M. Posadas, James X. Wu, Madhuri Wadehra, Myung‐Shin Sim, Yunfeng Li, Hanlin L. Wang, Samuel W. French, Shelly C. Lu, Lily Wu, Renjun Pei, Li Liang, Ju Dong Yang, Vatche G. Agopian, Hsian‐Rong Tseng, Yazhen Zhu
Publikováno v:
Hepatology. 77:774-788
The sensitivity of current surveillance methods for detecting early-stage hepatocellular carcinoma (HCC) is suboptimal. Extracellular vesicles (EVs) are promising circulating biomarkers for early cancer detection. In this study, we aim to develop an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba65effbecbbd94cfd6340364de74ed3
https://doi.org/10.1002/hep.32692
https://doi.org/10.1002/hep.32692
Autor:
Hope S, Rugo, Seock-Ah, Im, Anil A, Joy, Yaroslav, Shparyk, Janice M, Walshe, Bethany, Sleckman, Sherene, Loi, Kathy Puyana, Theall, Sindy, Kim, Xin, Huang, Eustratios, Bananis, Reshma, Mahtani, Richard S, Finn, Véronique, Diéras
Publikováno v:
The Breast. 66:324-331
BackgroundPrevious analyses from the PALOMA-2 and PALOMA-3 studies showed that palbociclib (PAL) plus endocrine therapy (ET) prolongs time to first subsequent chemotherapy (TTC) versus placebo (PBO) plus ET in the overall population of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a2d0aef9a153ade8d0c0dd05bb04441
https://doi.org/10.1016/j.breast.2022.11.005
https://doi.org/10.1016/j.breast.2022.11.005